Table 3 Cardiac Magnetic Resonance Results Before and After 2 Vaccination Doses (n = 67)
Before 1st vaccine dose | After 2nd vaccine dose | p-value | |
|---|---|---|---|
LV EDV Indexed (ml/m2) | 81 \(\pm\) 12 | 81 \(\pm\) 12 | 0.798 |
LV ESV Indexed (ml/m2) | 35 \(\pm\) 7.0 | 35 \(\pm\) 8.2 | 0.854 |
LV EF (%) | 58 \(\pm\) 5.0 | 57 \(\pm\) 5.3 | 0.088 |
LV Mass Indexed (g/m2) | 46 \(\pm\) 8.4 | 45 \(\pm\) 8.6 | 0.094 |
Cardiac Index (L/min/m2) | 3.3 \(\pm\) 0.50 | 3.2 \(\pm\) 0.6 | 0.431 |
Global Longitudinal Strain (%) | 17 \(\pm\) 2.0 | 17 \(\pm\)1.8 | 0.881 |
RV EDV Indexed (ml/m2) | 87 \(\pm\) 18 | 87 \(\pm\) 15 | 0.987 |
RV ESV Indexed (ml/m2) | 40 \(\pm\)9.2 | 41 \(\pm\) 9.7 | 0.627 |
RV EF (%) | 54 \(\pm\) 5.5 | 54 \(\pm\) 5.7 | 0.412 |
LA Area Corrected (cm2/m2) | 13 \(\pm\) 1.8 | 12 \(\pm\) 1.8 | 0.088 |
RA Area Corrected (cm2/m2) | 12 \(\pm\) 2.2 | 12 \(\pm\) 2.6 | 0.329 |
Pericardial Effusion (n, %) | 1 (1.5%) | 1 (1.5%) | 1.00 |
Global Native T1 Myocardium (msec) | 1045\(\pm\)50 | 1055 \(\pm\) 55 | 0.303 |
Global Native T2 Myocardium (msec) | 49.5 \(\pm\) 4.2 | 50.5 \(\pm\) 4.4 | 0.191 |
ECV Myocardium (%) | 27.9 \(\pm\) 3.8 | 27.8 \(\pm\) 4.4 | 0.901 |
LGE Present | 1 (1.5%) | 1 (1.5%) | 1.00 |
T2 STIR Abnormalities | 0 | 0 | 1.00 |
Lake Louise Criteria Fulfilled (%) | 0% | 0% | 1.00 |